427 related articles for article (PubMed ID: 19898981)
1. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
[TBL] [Abstract][Full Text] [Related]
2. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
3. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
Poh TW; Bradley JM; Mukherjee P; Gendler SJ
Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
[TBL] [Abstract][Full Text] [Related]
4. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
Su Z; Zhang Y; Ni P; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
[TBL] [Abstract][Full Text] [Related]
6. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.
Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K
Oncotarget; 2015 May; 6(14):12369-82. PubMed ID: 25869209
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
9. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
11. CD11b+ Ly6Chi Ly6G- immature myeloid cells recruited in response to Salmonella enterica serovar Typhimurium infection exhibit protective and immunosuppressive properties.
Tam JW; Kullas AL; Mena P; Bliska JB; van der Velden AW
Infect Immun; 2014 Jun; 82(6):2606-14. PubMed ID: 24711563
[TBL] [Abstract][Full Text] [Related]
12. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells.
Ryzhov S; Novitskiy SV; Goldstein AE; Biktasova A; Blackburn MR; Biaggioni I; Dikov MM; Feoktistov I
J Immunol; 2011 Dec; 187(11):6120-9. PubMed ID: 22039302
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
[TBL] [Abstract][Full Text] [Related]
14. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.
Serafini P; Carbley R; Noonan KA; Tan G; Bronte V; Borrello I
Cancer Res; 2004 Sep; 64(17):6337-43. PubMed ID: 15342423
[TBL] [Abstract][Full Text] [Related]
15. Poly(I:C) induce bone marrow precursor cells into myeloid-derived suppressor cells.
Liu C; Zhang C; Lu H; Cai J; Wang Z; Chen J; Liu F; Wu Z; Liu X; Sun W
Mol Cell Biochem; 2011 Dec; 358(1-2):317-23. PubMed ID: 21744070
[TBL] [Abstract][Full Text] [Related]
16. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
17. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of B220
Zhang Z; Huang X; Wang E; Huang Y; Yang R
Oncoimmunology; 2021 Apr; 10(1):1912472. PubMed ID: 33948392
[TBL] [Abstract][Full Text] [Related]
19. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
20. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
